Company / R&D per Share
Annexon, Inc. R&D per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.87
FY2024
5-year range
$0.87 / $2.90
FY2020-FY2024
Trend
-42.2%
vs FY2023
Sector context
#152 of 207
Health Care
What the data says
At $0.87, Annexon, Inc.'s r&d per share ranks #152 of 207 in the Health Care sector. R&D per Share has declined for 5 consecutive years, from $56.57 in FY2019 to $0.87 in FY2024.
Based on SEC 10-K filings.
0.87 in FY2024 with a 5-year CAGR of -56.6%.
Declined from $2.06 to $0.87 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -30.7%
- 5-Year CAGR
- -56.6%
- 10-Year CAGR
- -
Sector benchmark
#152 of 207 in Health CareTop 73% of 207This company $0.87 Sector average $12.26
▼
-92.9% below sector average
Key checks
Key Insights
- Annexon, Inc.'s r&d per share has declined for 5 consecutive years.
- In FY2024, r&d per share decreased 42.2% year-over-year.
- Ranks #152 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.87 | -42.2% |
| FY2023 | $1.50 | -26.9% |
| FY2022 | $2.06 | -21.2% |
| FY2021 | $2.61 | -10.1% |
| FY2020 | $2.90 | -94.9% |
| FY2019 | $56.57 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026